Business Context and Reporting Period
Company: Amgen Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 30, 2026
Reporting Period: First Quarter 2026 (Three months ended March 31, 2026)
This filing announces the issuance of a press release containing unaudited results of operations and financial position for the first quarter of 2026. The report includes both GAAP and non-GAAP financial measures.
Key Financial Metrics
The provided text serves as a cover document for the earnings press release (Exhibit 99.1) and does not contain specific numerical values for the following metrics:
- Revenue: Not provided in this text.
- Profit: Not provided in this text.
- Cash Flow: The filing mentions the use of Free Cash Flow (FCF), defined as operating cash flow minus capital expenditures, but does not state the specific amount.
- Margins, Debt, and Liquidity: Specific figures are not included in this excerpt.
The filing details the methodology for non-GAAP adjustments, including exclusions for acquisition-related expenses, restructuring costs, and other unusual items, but does not list the resulting financial totals.
Material Changes and Non-GAAP Adjustments
The filing outlines specific categories of costs excluded from GAAP measures to calculate non-GAAP results, which may impact period-over-period comparisons:
- Acquisition-related expenses: Includes amortization and impairment of intangible assets (e.g., technology rights, licensing rights) and step-up to fair value of acquired inventory.
- Restructuring and cost savings: Includes facility charges, asset impairments, accelerated depreciation, and severance/benefits for terminated employees.
- Other items: Includes gains/losses on equity securities and items associated with legal proceedings.
The text notes that these charges vary in amount and timing, and their exclusion is intended to facilitate comparisons of ongoing business operations.
Guidance, Outlook, and Management Commentary
Management Commentary: Management states that non-GAAP measures are used internally for budgeting, financial planning, resource allocation, and evaluating incentive compensation targets. They believe these measures provide a supplemental evaluation of current operating performance and liquidity.
Guidance and Outlook: The provided text does not contain specific forward-looking guidance, revenue projections, or updated outlook statements for future periods.
Risks and Contingencies: The filing references "certain items associated with legal proceedings" as an adjustment category but does not detail specific legal risks or contingencies in this summary text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 30, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific dollar amounts of acquisition-related amortization and restructuring charges excluded from non-GAAP results.
- Confirm the Free Cash Flow calculation details and capital expenditure amounts.
- Check for any legal proceedings details mentioned in the full press release that contributed to the "other items" adjustment.
- Compare the reported non-GAAP tax rate against the effective GAAP tax rate to understand the impact of tax law changes or jurisdictional differences.